Nature Genetics and Nature Reviews Cancer present:

Nuclear Reprogramming and the Cancer Genome 2016

Sponsored by CapitalBio Corporation

February 21-23, 2016
Estancia La Jolla Hotel, La Jolla, CA, USA

Understanding how cell fate is controlled is fundamental to all aspects of biology. Potentially, there are many states that cells could adopt based on thousands of genetic and epigenetic elements, but in reality cell fate is constrained by signals from surrounding cells and environments. One clear example of this was shown by the transfer of a nucleus from a melanoma cell into a mouse oocyte, which produced a totipotent embryonic cell. Why and how does this reprogramming occur? This conference aims to bring together researchers working on nuclear reprogramming, cancer genomics and the functional analysis of cancer cells to see just how much we can learn from one another.

Nuclear Reprogramming and the Cancer Genome 2016
Sponsored by CapitalBio Corporation

• Scientific Committee

  • Shu Chien (University of California, San Diego, USA)
  • Natalie DeWitt (Accendo Science Editing and NDA Partners, USA)
  • Tiago Faial (Nature Genetics, US)
  • Catriona Jamieson (University of California, San Diego, USA)
  • Xin Lu (Ludwig Institute for Cancer Research, University of Oxford, UK)
  • Bing Ren (Ludwig Institute for Cancer Research, University of California, San Diego, USA)
  • Sarah Seton-Rogers (Nature Reviews Cancer, UK)
  • Yang Xu (University of California, San Diego, USA)
  • Kang Zhang (University of California, San Diego, USA)

• Date

  February 21-23, 2016

• Venue

  Estancia La Jolla Hotel, La Jolla, CA

Main navigation